Neurofeedback Intervention in Children With Autism Spectrum Disorder (ASD)
NCT ID: NCT05254769
Last Updated: 2022-03-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
35 participants
INTERVENTIONAL
2021-11-15
2022-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* explore the effectiveness of Neurofeedback therapy for children diagnosed with Autism Spectrum Disorder (ASD)
* assess if cognitive functions are affected before and after Neurofeedback Intervention
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Virtual Discrete Trial Training on Children With Autism Spectrum Disorder
NCT06522490
Neurofeedback Training for Autistic Children
NCT07149974
Effects of Qigong Sensory Training on Sensory Modulation and Behavior in Children With Autism
NCT06893679
Augmented Reality Game-based Training on Social Communication of Children With Autism Spectrum Disorder
NCT05931094
Neurofeedback Therapy for Children Diagnosed With Autism
NCT02773303
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Goal is to improve the quality of life of children on the spectrum by enabling them to perform day to day activities of life and to improve their social communication. Moreover, this study seeks to be a contribution for creating mass awareness regarding the efficacy of Neurofeedback therapy especially in the developing world. Hopefully in the future Neurofeedback training would be incorporated as a standard of care for ASD.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Neurofeedback Intervention in children with Autism Spectrum Disorder
Neurofeedback therapy will be provided to 35 children with Autism Spectrum Disorder 30 sessions each and cognitive domains will be assessed before and after intervention.
Neurofeedback Equipment (Cygnet) by BEE Medic GmbH Technologies, Baden-Wurttemberg, Germany.
The EEG NeuroAmp (Electroencephalogram Amplifier) is a user-friendly high-performance interface between client and clinician computer. It can be used in two different functionalities: In an EEG/ERP (Event related potential) measurement and in an EEG biofeedback (neurofeedback) and/or peripheral biofeedback setting.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neurofeedback Equipment (Cygnet) by BEE Medic GmbH Technologies, Baden-Wurttemberg, Germany.
The EEG NeuroAmp (Electroencephalogram Amplifier) is a user-friendly high-performance interface between client and clinician computer. It can be used in two different functionalities: In an EEG/ERP (Event related potential) measurement and in an EEG biofeedback (neurofeedback) and/or peripheral biofeedback setting.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Bipolar Disorder
* Tourette's Syndrome
* Uncontrolled seizure disorder
* Major psychiatric disorder
* Children on medications
7 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Khyber Medical University Peshawar
OTHER
Shaheed Zulfiqar Ali Bhutto Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Shemaila Saleem
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shemaila Saleem
Role: PRINCIPAL_INVESTIGATOR
FM&DC, Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, Pakistan
Hamid Habib
Role: PRINCIPAL_INVESTIGATOR
Khyber Medical University, Peshawar, Pakistan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federal Medical and Dental College, Shaheed Zulfiqar Ali Bhutto Medical University
Islamabad, , Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NFB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.